Research at MD Anderson
Research fuels our mission to end cancer
Many of the greatest minds in cancer research are at MD Anderson. They're here because MD Anderson offers a unique environment that accelerates their ability to end cancer. They collaborate with other cancer experts – in different research areas and with the world's leading cancer doctors. Bright students and trainees contribute further to our dynamic research environment. Discoveries are fueled by vast research support and resources. Tomorrow's medicine is available to our patients first since we have the most cancer clinical trials in the world. These research efforts work in parallel to fight cancer through prevention, early diagnosis, effective therapies and scientific breakthroughs.
FY20 Research Publication Statistics
MD Anderson faculty shared their expertise by contributing to over
4,600 total articles, editorials and reviews in the 2020 fiscal
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Our laboratories cover the full breadth of cancer research. They’re led by some of the leading scientists and physicians in the world.
Scientists from different disciplines come together to focus on a common area in our research institutes.
Meet our cancer researchers
MD Anderson faculty focus on a variety of research topics that contribute to our goal of ending cancer.
Moon Shots Program
Inspired by an unprecedented era of scientific discovery a generation ago, the Moon Shots Program? was launched by MD Anderson as an ambitious plan to make a giant leap in cancer research to benefit patients.Learn more about the Moon Shots Program
Diagnostic imaging test
Breast cancer treatment
Lung cancer trial
Phase III VIALE-A trial
Twelve MD Anderson researchers honored with 2020 AACR Team Science Awards
A group of 12 MD Anderson researchers were recognized for their role in The Cancer Genome Atlas at the 2020 American Association for Cancer Research Team Science Awards. The Cancer Genome Atlas was launched in 2006 as a joint endeavor between the National Cancer Institute (NCI) and the National Human Genome Research Institute. It was created to bring together multidisciplinary teams of researchers from across many institutions with the goal of improving understanding of cancer by cataloging genetic alterations found in tumor samples.
The Father of Tamoxifen
V. Craig Jordan, Ph.D., repurposed a contraceptive to treat breast cancer.